Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mirabilis Medica Inc.

Latest From Mirabilis Medica Inc.

Recent Financings Of Private Companies, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.

BioPharmaceutical Medical Device

Medical Device Deals Update, August 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity.

Medical Device

Women's Health: Numbers Too Big To Ignore

The women's health opportunity in the US is $2.75 billion on an annual basis, and it's growing at a compounded rate of 16% per year. Looking forward, demographics, the aging of the population, and technological innovations will continue to fuel growth. New technologies promise to cause one particular category in women's health to blossom; the treatment of uterine fibroids. According to "Women's Health: US Markets for Benign Uterine Condition Management Products," a report recently published by the Medtech Insight division of Windhover Information Inc., the number of fibroid treatments is expected to increase at a compound annual rate of 21.3%. The report also discusses the markets for the treatment of menorrhagia and endometriosis.
Medical Device

Start-Up News August 2007

In women's health, Novian offers a micro-invasive alternative to lumpectomy. Mirabilis Medica hopes to introduce a non-invasive in-office procedure for the removal of uterine fibroids. Dyn-Bioshaf believes that diagnostics that pinpoint the particular cause of infertility will ultimately help improve the success rates of the In Vitro Fertilization industry.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Mirabilis Medica Inc.
  • Senior Management
  • Jens U Quistgaard, CEO
    Michael H Lau, MD, Pres. & CMO
  • Contact Info
  • Mirabilis Medica Inc.
    Phone: (425) 486-8230
    18706 North Creek Pkwy
    Ste. 110
    Bothell, WA 98011